Webinar | March 8, 2017

Visibility and Oversight: What Paper Informed Consent Isn't Offering You (Featuring Guest Speaker, Chesapeake IRB)

Source: Signant Health

By Sandra “SAM” Sather, Quality and Regulatory, TrialConsent, CRF Health, Jeff Wendel, CEO & President, Chesapeake IRB, and Lauri Carlile, Executive Director, Chesapeake IRB

Chesapeake IRB and CRF Health team up for a collaborative webinar to discuss informed consent oversight and visibility and why Top Pharma is turning to Electronic Informed Consent (eConsent) to exceed in these areas.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Signant Health